Workflow
Retail Sales Show Resilience in July: Sector ETFs in Focus
ZACKSยท2025-08-20 11:00

Retail Sales Overview - Retail sales in the United States increased by 0.5% sequentially in July 2025, following a revised 0.9% rise in June, aligning with market expectations [1] - The largest increases were in sales at motor vehicle & parts dealers (1.6%) and furniture & home furnishing stores (1.4%) [1] - Other notable gains included sporting goods, hobby, musical instrument, & book stores (0.8%), nonstore retailers (0.8%), clothing & clothing accessories stores (0.7%), and gasoline stations (0.7%) [1] Online Sales - Nonstore retailers experienced a 0.8% sequential increase and an 8.0% yearly gain [3] - ProShares Online Retail ETF (ONLN) tracks retailers primarily selling online or through non-store channels, with a fee of 58 basis points [3] - Amazon.com (AMZN) is highlighted as a major e-commerce provider with a Zacks Rank of 3 (Hold) [4] Clothing Stores - Sales in clothing stores rose by 0.7% sequentially in July and 5% year over year [5] - SPDR S&P Retail ETF (XRT) provides exposure to U.S. retail stocks, with apparel retail comprising about 21% of the fund, charging 35 basis points in fees [5] - Levi Strauss & Co. (LEVI) is noted for designing and marketing jeans and casual wear, holding a Zacks Rank of 1 (Strong Buy) [5] Furniture & Home Furnishing Stores - Sales for furniture & home furnishing stores increased by 1.4% sequentially and 5.1% year over year [6] - iShares U.S. Consumer Focused ETF (IEDI) focuses on U.S. companies related to consumer spending, charging 18 basis points in fees [6] - Home Depot (HD) is recognized as the world's largest home improvement specialty retailer, with a Zacks Rank of 3 [6] Health & Personal Care Stores - Sales for health & personal care stores rose by 0.4% sequentially and 5.6% year over year [7] - iShares U.S. Healthcare Providers ETF (IHF) aims to match the performance of the Dow Jones U.S. Select Health Care Providers Index, charging 40 basis points in fees [7] - CVS Health (CVS) is identified as a pharmacy innovation company with a Zacks Rank of 2 (Buy) [7]